IFNA1 and myeloid sarcoma: TLR signaling results in the activation of T cells [7] and production of pro-inflammatory cytokines, such as interleukin (IL)-12β, interferon (IFN) and tumor necrosis factor (TNF)-α, which are known to be increased in patients with MS [5,8,9].